Form DRS/A - Draft Registration Statement: [Amend]
SEC Accession No. 0001564590-17-018945
Filing Date
2017-09-22
Accepted
2017-09-22 15:15:02
Documents
5

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS/A 83199
2 filename2.htm EX-10 352328
3 filename3.htm EX-10 372009
4 filename4.htm EX-10 451475
5 filename5.htm EX-10 118539
  Complete submission text file 0001564590-17-018945.txt   1378695
Mailing Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139
Business Address 675 MASSACHUSETTS AVENUE 14TH FLOOR CAMBRIDGE MA 02139 857-242-1600
Spero Therapeutics, Inc. (Filer) CIK: 0001701108 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS/A | Act: 33 | File No.: 377-01690 | Film No.: 171097509
SIC: 2834 Pharmaceutical Preparations